No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas.

The article discusses a study on whether there is a need to screen N-methyl-D-aspartate receptor antibody in patients with ovarian teratomas and without symptoms of autoimmune encephalitis. Topics mentioned include the link between NMDAR encephalitis and OT, a recommendation on the need to exclude the presence of OT in patient with NMDAR encephalitis, and the improvement of clinical management of OT patients after screening for elevated NMDAR antibodies.